AzTrials
AzTrials

Surgery DateRM BREAST QNCT07699913

Quality of Life of Patients Who Have Undergone Bilateral Mastectomy

An observational study of Surgery Date and Age, run by University Hospital, Grenoble.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The investigators therefore aim to determine whether the type of mastectomy (preventive in a high-risk patient or therapeutic in a patient with a history of cancer), as well as the timing (immediate or delayed) and type of breast reconstruction, influence the quality of life and satisfaction of patients who have… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Surgery Date, Age, BMI
How many people
115 participants
Where
No sites listed yet
Study dates
10 Jul 2026to 20 Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients treated at CHU Grenoble Alpes for bilateral breast reconstruction between January 1, 2015, and January 1, 2026, in the plastic surgery and gynecology departments (departments performing breast reconstruction procedures).

Who may be able to join

  • Female sex
  • Age ≥ 18 years
  • Bilateral mastectomy
  • Breast reconstruction between January 1, 2015, and January 1, 2026
  • No objection to the study

Who cannot join

  • Individual under guardianship or curatorship, or deprived of liberty
  • Reconstruction not completed by January 1, 2026.

About this study

Official title: Psychological Experience, Quality of Life, and Patient Satisfaction Following Bilateral Breast Reconstruction After Prophylactic or Therapeutic Mastectomy, Using the BREAST-Q Questionnaire.

The investigators therefore aim to determine whether the type of mastectomy (preventive in a high-risk patient or therapeutic in a patient with a history of cancer), as well as the timing (immediate or delayed) and type of breast reconstruction, influence the quality of life and satisfaction of patients who have undergone bilateral mastectomy. The goal of this observational study is thus to measure and compare the quality of life of patients who have undergone bilateral mastectomy using the BREAST-Q questionnaire.

Keywords
Comparative, observational, retrospective
Medical subject headings
Body Weight, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07699913
Study groupRoleWhat they receive
Bilateral prophylactic mastectomyThe investigators will compare patients who underwent prophylactic bilateral mastectomy, prophylactic therapeutic and prophylactic and therapeutic mastectomy
Bilateral therapeutic mastectomyThe investigators will compare patients who underwent prophylactic bilateral mastectomy, prophylactic therapeutic and prophylactic and therapeutic mastectomy
Therapeutic and prophylactic mastectomyThe investigators will compare patients who underwent prophylactic bilateral mastectomy, prophylactic therapeutic and prophylactic and therapeutic mastectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of the BREAST Q Questionnaire

    Composite score on the standardized BREAST-Q questionnaire for the following domains: psychosocial well-being, sexual well-being, physical well-being, and breast satisfaction, starting at 3 months postoperatively.

    A conversion table allows for conversion of the raw scale summed score into a score from 0 (worst) to 100 (best). Higher scores reflect a better outcome.

    Measured: 3 months post operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2026
  2. Study start10 Jul 2026 (estimated)
  3. Primary completion30 Jul 2026 (estimated)
  4. Study completion20 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
115 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07699913
Sponsor's protocol ID
2026-A00794-47
Acronym
RM BREAST Q
Status last verified
Jul 2026
First submitted
7 Jul 2026
Last updated
15 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Surgery Date and Age, run by University Hospital, Grenoble.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of the BREAST Q Questionnaire (time frame: 3 months post operatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in